Dr. Joshua C. Bramson, MD

Dr. Bramson practices at Hmhmg Specialty Care in Hackensack, New Jersey.

Dr. Bramson's NPI, 1902937105, was assigned on March 8, 2007. Dr. Bramson holds New Jersey license 25MA11113200.

Dr. Bramson's primary practice is Hmhmg Specialty Care, at 360 Essex St, Hackensack, NJ 07601 in Bergen County. The practice phone is (732) 807-0800.

Dr. Bramson's primary practice is Hmhmg Specialty Care in Hackensack, New Jersey. Dr. Bramson is also affiliated with Jersey Shore University Medical Center. The medical group on file is Hackensack Meridian Medical Group. Dmand AI also links Dr. Bramson to 3 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bramson practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Bramson's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Bramson is licensed in New Jersey.

CMS data shows 1,744 Medicare services from Dr. Bramson across 11 procedure codes in 2024, for 822 Medicare patients. Medicare paid $195,749 for them.

CMS counts 822 Medicare patients who saw Dr. Bramson in 2024. The largest group is 75 to 84, with 335 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.35, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bramson's median patient age at 70, with 59% women.

In 2024, Dr. Bramson wrote 767 Medicare Part D claims for 154 patients. 86% of them were for generic drugs. CMS names the drug for 542 of them, across 23 drugs with 11 or more claims each, at $380,544 in total drug cost. In 2023, CMS named 335 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Bramson for performance year 2024, reported as part of a group. Dr. Bramson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bramson as offering telehealth.

Dmand AI links 2 papers to Dr. Bramson, published from 2019 to 2023. Dr. Bramson's most frequent co-authors are Alireza Amirpour, Ravneet Bajwa, MD and Saira Chaughtai.

CMS Open Payments shows 200 general payments to Dr. Bramson from 42 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 87% of the total. Bristol-Myers Squibb Company paid the most, $467.